Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Developing Country Farmers Bridge the ‘Biotechnology Divide’

Published: Monday, February 25, 2013
Last Updated: Monday, February 25, 2013
Bookmark and Share
Critics of agricultural biotechnology have long contended that it would not benefit farmers in developing countries. Their concerns were not unjustified.

A large number of technologies continue to be restricted to industrialized countries despite their global relevance.

Farmers in developing countries, however, are bridging the "biotechnology divide." According to a new report by Clive James of the International Service for the Acquisition of Agri-Biotech Applications (ISAAA), "For the first time, developing countries grew more, 52% of global biotech crops in 2012 than industrialized countries at 48%."

The report, Global Status of Commercialized Biotech/GM Crops: 2012, notes that this is "contrary to the predictions of critics who, prior to the commercialization of the technology in 1996, prematurely declared that biotechnology were only for industrial countries and would never be accepted and adopted by developing countries."

It is notable that over the last year two new developing countries (Sudan and Cuba) joined the club of agricultural biotechnology, while Poland, Germany, and Sweden stopped growing transgenic crops. It is unlikely that the European Union will relax its regulations in the near future. As a result, future growth in biotechnology adoption will occur in developing countries.

Sudan's biotechnology lessons are likely to inspire other countries in the region. Cuba's entry into crop biotechnology is significant because of the country's emphasis on using the technology to promote ecologically-sound and pesticide-free crops. Both Sudan and Cuba have a history of giving priority to domestic agricultural research.

Agricultural biotechnology is the fastest adopted crop technology over the last century. According to the report, "2012 marked an unprecedented 100-fold increase in biotech crop hectarage from 1.7 million hectares in 1996 to 170 million hectares in 2012." This consistent adoption of transgenic crops is an indication they farmers find them valuable.

These shifting trends also have been accompanied by more economic benefits accruing to developing countries. According to the report, during "the period 1966–2011 cumulative economic benefits were high in developing countries at US$49.6 billion compared to US$48.6 billion generated by industrial countries."

So far the main traits being adopted are the same ones initially developed for industrialized countries. The main policy challenge for developing countries is the extent to which the technology will be adapted to meet new needs rather than extend the use of existing crops.

The analogy for this kind of thinking can be found in the evolution of the mobile phone. Initially developed for communication, mobile phones are now being deployed in banking, health, education, and emergency services in developing countries.

Emerging evidence suggests that developing countries are starting to focus their attention on adapting biotechnology to local needs. This process is also associated with the development of domestic biotechnology capacity as part of the expansion of the "freedom to innovate."

Two examples illustrate this shift. In Nigeria scientists have developed a pest-resistant variety of the blackeyed pea, a subspecies of the cowpea (Vigna unguiculata). The crop is often attacked by the insect Maruca vitrata, resulting in an annual loss of US$300 million to smallholder farmers. The main method to control the pest is to spray pesticides, which cost the countries nearly US$500 million annually. Africa is the world's leading producer of the blackeyed pea, accounting for nearly 70% of the market—or about 6.1 million tons.

To address the problem, scientists at the Institute for Agricultural Research at Nigeria's Ahmadu Bello University in Zaria have developed a transgenic blackeyed pea variety using insecticide genes from the Bacillus thuringiensis bacterium. This breakthrough demonstrated the existence of local capacity to apply existing techniques to unique African problems.

African crop diseases are also becoming the focus of local research. Bananas, for example, are a staple in Uganda and other parts of the Great Lakes region. The crop is threatened by Xanthomonas wilt, a bacterial disease that is costing Uganda nearly US$500 in banana losses.

Ugandan scientists are working to create a transgenic banana using genes extracted from sweet pepper (Capsicum annuum) to control Xanthomonas. The disease also has been reported in ensete banana (Ensete ventricosum), a staple crop in Ethiopia.

The Association for Strengthening Agricultural Research in Eastern and Southern Africa (ASARECA) has been at the forefront of supporting biotechnology research that addresses local needs. These include locally driven research on animal disease diagnostics, banana, cassava, beans, napier grass, and sweet potato.

These examples illustrate that lack of scientific capacity is no longer the most important barrier that African countries face in bridging the “biotechnology divide.” Many of them, with support from the United Nations, have put regulations in place that severely restrict the adoption of new biotechnology products.

These policies were initially developed to regulate imports of biotechnology products. Ironically, it appears that their most negative impacts are likely to be felt by local scientists who are working to solve pressing agricultural problems that affect staple foods in the region.

The rising adoption of transgenic crops by tropical countries, however, will also increase opportunities for international cooperation, given the similarities in ecological and economic conditions. Such cooperation will help enhance trust in the technology and facilitate adoption.

What is needed, as Clive James highlights, is "responsible, rigorous but not onerous, regulation." Without such regulation, farmers in developing countries will continue to be denied the benefits of biotechnology by the misguided policies and regulations of their own governments.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Plant Analysis – Identifying Metabolites
New plant analysis method shows biologically active plant substances are far more common than previously thought.
New Mechanism to Control Human Viral Infections Discovered
Researchers discover long sought after mechanism in human cells that could help treat diseases caused by viruses.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
Immune-Cell Traps May Aid Cancer Metastasis
Study suggests cancer cells can induce neutrophils to release traps which the cells use to capture pathogens.
Exploring the Genome of the River Blindness Parasite
Researchers have decoded the genome of the parasite that causes the skin and eye infection known as river blindness.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!